MANGALAM Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > mangalam

Technical Analysis

Technical Strength: 7.4 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 55.0. According to RSI analysis, mangalam is technically strong. 9.0 MANGALAM RSI Chart
MACD (?) MACD: 1.34 and Signal Line: 1.32. According to MACD analysis, mangalam is technically strong. 8.0 MANGALAM MACD Chart
Simple Moving Average (?) According to simple moving average analysis, mangalam is facing resistance from it's 200-day simple moving average at 43.55 and support level is at 32.7. 7.0 MANGALAM Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, mangalam is facing resistance from it's 200-day exponential moving average at 46.09715 and support level is at 32.9. 7.0 MANGALAM Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.612. 5.0 MANGALAM Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, price is above 61.8% and 50% level. Support is at 32.475 and 31.0649. Resistance level is 33.8851. 8.0 MANGALAM Fibonacci Retracement Chart
Average True Range (?) ATR: 2.15 NA MANGALAM Average True Range Chart
Average Directional Index (?) ADX is 24.7 which means MANGALAM is in a trading range and there is no trend. NA MANGALAM Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 28, 2020
Open Price 36.3
High Price 36.5
Low Price 33.5
Close Price 33.8
Absolute Change -1.4
Percentage Change -3.98%
Weekly Change -6.76%
Monthly Change 22.9%
Yearly Change -59.4%
52-week high 87.9
52-week low 24.15
Corporate Actions
ExDate Purpose
September 17, 2018 ANNUAL GENERAL MEETING
December 21, 2017 INT DIV RE 0.50 PER SHARE
September 18, 2017 Annual General Meeting
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)0.853
Confidence in Beta1.91%
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 28 January 2020: Deliverable Quantity:2.76e+04 NA MANGALAM Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 28 January 2020: Daily Volatility:0.6916 NA MANGALAM Annualized Daily Volatility (Spot Price) Chart

Announcements

July 22, 2019 Clarification MANGALAM:The Exchange has sought clarification from Mangalam Drugs And Organics Limited with respect to announcement dated 08-Jul-2019, about the following changes: 1. Resignation of Ms. Nikita Bavishi as Company Secretary & Compliance officer of the company w.e.f. closure of business hours of 08th July, 2019. 2. Appointment of Ms. Geeta G. Karira as Company Secretary & Compliance officer of the company w.e.f. 09th July, 2019. On basis of above the Company is required to clarify following: 1. Brief profile (in case of appointment). The response of the Company is awaited.
February 12, 2018 MaOutcome of Board Meetingangalam Drugs And Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on February 12, 2018.
See all Announcements

Board Meetings

Date Meeting Date Purpose
January 17, 2020 January 24, 2020 Financial Results Pursuant to Regulation 29, 33 and other applicable provisions, if any, of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, we have to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday, January 24, 2020 at the registered office of the Company at Mumbai, inter-alia to consider and approve the Un-Audited Financial Results of the Company for the quarter ended December 31, 2019.
October 25, 2019 November 02, 2019 Financial Results To consider and approve the Un-Audited financial results for the period ended September 30, 2019 and other business items.
See all Board Meetings

Get Clearnifty's Android App.

Get clearnifty on Google Play
Get clearnifty on Google Play